Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Impax US Sustainable Economy Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"The Impax US Sustainable Economy Fund outperformed the Russell 1000 in Q4 2025, buoyed by positive stock selection in Health Care and the successful risk-mitigation of its proprietary ESG and Corporate Resilience filters."
In Q4 2025, the Impax US Sustainable Economy Fund (Institutional Class) returned 4.23%, outperforming the Russell 1000 benchmark return of 2.41%. Outperformance was driven by positive stock selection in Health Care (Eli Lilly, Merck) and Financials (Visa, State Street), alongside favorable exposure to higher Corporate Resilience profiles and specific industry tilts via the Impax Sustainability Lens. Detractors included Oracle (AI capex debt concerns) and Zoetis (slower pipeline growth). The managers entered 2026 with a cautious but optimistic outlook, prioritizing robust balance sheets and secular growth drivers amidst shifting interest rate and regulatory environments.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: The Impax US Sustainable Economy Fund outperformed the Russell 1000 in Q4 2025, buoyed by positive stock selection in Health Care and the successful risk-mitigation of its propriet...
Growth Outlook
Market outlook remains above average conviction: The Impax US Sustainable Economy Fund outperformed the Russell 1000 in Q4 2025, buoyed by positive stock selection in Health Care and the successful risk-mitigation of its propriet...
Risk Appetite
Risk appetite posture is above average conviction: The Impax US Sustainable Economy Fund outperformed the Russell 1000 in Q4 2025, buoyed by positive stock selection in Health Care and the successful risk-mitigation of its propriet...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The Impax US Sustainable Economy Fund outperformed the Russell 1000 in Q4 2025, buoyed by positive stock selection in Health Care and the successful risk-mitigation of its propriet...
Forward Guidance
Forward guidance signal: The Impax US Sustainable Economy Fund outperformed the Russell 1000 in Q4 2025, buoyed by positive stock selection in Health Care and the successful risk-mitigation of its propriet...
Language Signal
Tone analysis indicates above average conviction language: The Impax US Sustainable Economy Fund outperformed the Russell 1000 in Q4 2025, buoyed by positive stock selection in Health Care and the successful risk-mitigation of its propriet...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The Impax US Sustainable Economy Fund outperformed the Russell 1000 in Q4 2025, buoyed by positive stock selection in Health Care and the successful risk-mitigation of its propriet...
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. The Impax US Sustainable Economy Fund outperformed the Russell 1000 in Q4 2025, buoyed by positive stock selection in Health Care and the successful risk-mitigation of its propriet...
Time Horizon
Investment time horizon reflects a high conviction orientation. The Impax US Sustainable Economy Fund outperformed the Russell 1000 in Q4 2025, buoyed by positive stock selection in Health Care and the successful risk-mitigation of its propriet...
